	US 12,338,266 B2
	Montelukast esters and pharmaceutical compositions containing the same
Giuseppe Caliendo, Marigliano (IT); Giuseppe Cirino, Naples (IT); Ferdinando Fiorino, Benevento (IT); Francesco Frecentese, Aversa (IT); Marcelo Nicolas Muscara′, Campinas (BR); Elisa Perissutti, Venafro (IT); Antonio Petti, Battipaglia (IT); Vincenzo Santagada, Naples (IT); Beatrice Severino, Mugnano di Napoli (IT); and Fiorentina Roviezzo, Bonea (IT)
Assigned to GENETIC S.P.A., Castel San Giorgio SA (IT)
Appl. No. 17/629,914
Filed by GENETIC S.P.A., Castel San Giorgio (IT)
PCT Filed Aug. 4, 2020, PCT No. PCT/EP2020/071930 § 371(c)(1), (2) Date Jan. 25, 2022, PCT Pub. No. WO2021/023751, PCT Pub. Date Feb. 11, 2021.
Claims priority of application No. 102019000014178 (IT), filed on Aug. 6, 2019.
Prior Publication US 2022/0251136 A1, Aug. 11, 2022
Int. Cl. A61K 31/58 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); C07J 71/00 (2006.01)

CPC C07J 71/0031 (2013.01)

16 Claims

1. An ester of Montelukast with a corticosteroid selected from the group consisting of des-ciclesonide, triamcinolone, budesonide and flunisolide or a pharmaceutically acceptable salt, hydrate, or isomer thereof.